Sumitomo Dainippon Pharma Co (4506) Price & Analysis

Compare

1 Followers

4506 Stock Chart & Stats

Day’s Range― - ―

52-Week Range¥279.00 - ¥1,060.00

Previous CloseN/A

Volume1.08M

Average Volume (3M)13.78M

Market Cap

$311.08B

Enterprise Value¥672.02B

Total Cash (Recent Filing)$85.39B

Total Debt (Recent Filing)¥374.42B

Price to Earnings (P/E)13.3

Beta1.05

Next Earnings

Jul 30, 2025

EPS Estimate

-0.89

Last Dividend Ex-Date

Mar 30, 2023

Dividend YieldN/A

Share Statistics

EPS (TTM)6.08

Shares Outstanding397,900,150

10 Day Avg. Volume18,567,339

30 Day Avg. Volume13,778,983

Financial Highlights & Ratios

PEG Ratio-0.06

Price to Book (P/B)2.31

Price to Sales (P/S)0.00

P/FCF Ratio-23.03

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$900.68

Price Target Upside16.52% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Sumitomo Dainippon Pharma Co News

PremiumCompany Announcements

Sumitomo Pharma Restructures Asian Business with Marubeni Partnership

5h ago

PremiumCompany Announcements

Sumitomo Pharma Unveils ‘Reboot 2027’ for Strategic Growth

15d ago

PremiumCompany Announcements

Sumitomo Pharma Announces Significant Share Transfer in Asian Business

15d ago

PremiumCompany Announcements

Sumitomo Pharma Proposes Amendments to Enhance Governance

15d ago

PremiumCompany Announcements

Sumitomo Pharma Announces Key Personnel Appointments Amid Governance Transition

15d ago

PremiumPre-Earnings

DNPUF Earnings Report this Week: Is It a Buy, Ahead of Earnings?

17d ago

PremiumCompany Announcements

Sumitomo Pharma Announces Reversal of Doubtful Accounts Allowance

1M ago

PremiumCompany Announcements

Sumitomo Pharma Boosts Financial Forecasts and Records Gains from Equity Transfers

1M ago

See All JP:4506 News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

1.39%

Mutual Funds

― Other Institutional Investors

95.91% Public Companies and

Individual Investors

Detailed Ownership Overview >

4506 FAQ

What was Sumitomo Dainippon Pharma Co Ltd’s price range in the past 12 months?

Sumitomo Dainippon Pharma Co Ltd lowest stock price was ¥279.00 and its highest was ¥1060.00 in the past 12 months.

What is Sumitomo Dainippon Pharma Co Ltd’s market cap?

Sumitomo Dainippon Pharma Co Ltd’s market cap is $311.08B.

When is Sumitomo Dainippon Pharma Co Ltd’s upcoming earnings report date?

Sumitomo Dainippon Pharma Co Ltd’s upcoming earnings report date is Jul 30, 2025 which is in 63 days.

How were Sumitomo Dainippon Pharma Co Ltd’s earnings last quarter?

Sumitomo Dainippon Pharma Co Ltd released its earnings results on May 13, 2025. The company reported ¥6.08 earnings per share for the quarter, beating the consensus estimate of -¥12.32 by ¥18.4.

Is Sumitomo Dainippon Pharma Co Ltd overvalued?

According to Wall Street analysts Sumitomo Dainippon Pharma Co Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Sumitomo Dainippon Pharma Co Ltd pay dividends?

Sumitomo Dainippon Pharma Co Ltd pays a Annually dividend of ¥7 which represents an annual dividend yield of N/A. See more information on Sumitomo Dainippon Pharma Co Ltd dividends here

What is Sumitomo Dainippon Pharma Co Ltd’s EPS estimate?

Sumitomo Dainippon Pharma Co Ltd’s EPS estimate is -0.89.

How many shares outstanding does Sumitomo Dainippon Pharma Co Ltd have?

Sumitomo Dainippon Pharma Co Ltd has 397,900,150 shares outstanding.

What happened to Sumitomo Dainippon Pharma Co Ltd’s price movement after its last earnings report?

Sumitomo Dainippon Pharma Co Ltd reported an EPS of ¥6.08 in its last earnings report, beating expectations of -¥12.32. Following the earnings report the stock price went down -5.033%.

Which hedge fund is a major shareholder of Sumitomo Dainippon Pharma Co Ltd?

Currently, no hedge funds are holding shares in JP:4506

Company Description

Sumitomo Dainippon Pharma Co Ltd

Sumitomo Dainippon Pharma Co., Ltd. is a leading global pharmaceutical company headquartered in Japan. The company operates primarily in the healthcare sector, focusing on the research, development, manufacturing, and marketing of pharmaceutical products. Its core products span multiple therapeutic areas, including central nervous system disorders, oncology, diabetes, and infectious diseases. Sumitomo Dainippon Pharma is committed to improving healthcare outcomes through innovative solutions and collaborations.

4506 Company Deck

4506 Earnings Call

Q4 2025

0:00 / 0:00

Earnings Call Sentiment|Negative

The earnings call highlighted promising developments in the oncology and regenerative medicine pipelines but was overshadowed by significant financial losses, decreased revenue across all segments, and underperformance of key products, leading to a revised downward financial forecast. The call focused on strategic adjustments to address market challenges and improve profitability.Read More>

4506 Stock 12 Month Forecast

Average Price Target

¥900.68

▲(16.52%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"389":"¥389","1956":"¥1,956","780.75":"¥780.8","1172.5":"¥1,172.5","1564.25":"¥1,564.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1199.999999969904,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥1.20K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":900.6829823337,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥900.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":599.999999984952,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥600.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[389,780.75,1172.5,1564.25,1956],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2021","6":"Jul<br/>2024","9":"Jan<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,894,917.5384615361464,941.0769230722929,964.6153846084394,988.1538461445858,1011.6923076807323,1035.2307692168788,1058.769230753025,1082.3076922891717,1105.8461538253182,1129.3846153614645,1152.923076897611,1176.4615384337574,{"y":1199.999999969904,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,894,894.5140755641307,895.0281511282616,895.5422266923923,896.056302256523,896.5703778206539,897.0844533847846,897.5985289489154,898.1126045130461,898.626680077177,899.1407556413077,899.6548312054384,900.1689067695693,{"y":900.6829823337,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,894,871.3846153834578,848.7692307669157,826.1538461503735,803.5384615338314,780.9230769172892,758.307692300747,735.6923076842049,713.0769230676627,690.4615384511205,667.8461538345784,645.2307692180362,622.615384601494,{"y":599.999999984952,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1790.418,"date":1548979200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1790.418,"date":1583020800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1790.418,"date":1609459200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1618.813,"date":1614556800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1955.875,"date":1630454400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":400,"date":1714521600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":390,"date":1719792000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":473,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":607,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":563,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":610,"date":1738368000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":713,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":894,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >